Factors associated with mortality and default among patients with tuberculosis attending a teaching hospital clinic in Accra, Ghana

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 105, Issue 12, 2011, Pages 675-682

  Burton, Nicole T ^a,d   Forson, Audrey ^b   Lurie, Mark N ^a,d   Kudzawu, Samuel ^b   Kwarteng, Ernest ^b   Kwara, Awewura ^a,c  

^a BROWN UNIVERSITY   (United States)

^b KORLE BU TEACHING HOSPITAL   (Ghana)

^c MIRIAM HOSPITAL   (United States)

^d NONE

Author keywords

Default; Mortality; TB HIV coinfection; Treatment outcome; Tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADULT; AGED; ARTICLE; CAUSE OF DEATH; CONFIDENCE INTERVAL; DIRECTLY OBSERVED THERAPY; DISEASE CLASSIFICATION; FEMALE; GHANA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; MULTIVARIATE ANALYSIS; NONHUMAN; RISK FACTOR; SPUTUM SMEAR; TEACHING HOSPITAL; THORAX RADIOGRAPHY; TREATMENT RESPONSE; TUBERCULOSIS; TUBERCULOUS MENINGITIS;

ADOLESCENT; ADULT; AGED; ANTITUBERCULAR AGENTS; COINFECTION; FEMALE; GHANA; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV INFECTIONS; HOSPITALS, TEACHING; HUMANS; LOGISTIC MODELS; MALE; MEDICAL RECORDS; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PATIENT COMPLIANCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME; TUBERCULOSIS; YOUNG ADULT;

EID: 81055157828     PISSN: 00359203     EISSN: 18783503     Source Type: Journal    
DOI: 10.1016/j.trstmh.2011.07.017     Document Type: Article

References (38)

1. WHO. Global tuberculosis control. WHO Report 2010. Geneva: World Health Organization. WHO/HTM/TB/2010.7. 2010.
2. Lonnroth K., Castro K.G., Chakaya J.M., Chauhan L.S., Floyd K., Glaziou P., et al. Tuberculosis control and elimination 2010-50: cure, care, and social development. Lancet 2010, 375:1814-1829.
3. Selig L., Guedes R., Kritski A., Spector N., Lapa E.S.J.R., Braga J.U., et al. Uses of tuberculosis mortality surveillance to identify programme errors and improve database reporting. Int J Tuberc Lung Dis 2009, 13:982-988.
4. National AIDS/STI Control Programme. 2009 HIV Sentinel Survey Report. Accra: National AIDS/STI; 2009.
5. Control Programme, Ghana Health Service, Ministry of Health, Accra Ghana; 2010.
6. WHO. Treatment of tuberculosis guidelines. 4th ed. Geneva: World Health Organization. WHO/HTM/TB/2009.420; 2010.
7. Veen J., Raviglione M., Rieder H.L., Migliori G.B., Graf P., Grzemska M., et al. Standardized tuberculosis treatment outcome monitoring in Europe. Recommendations of a Working Group of the World Health Organization (WHO) and the European Region of the International Union Against Tuberculosis and Lung Disease (IUATLD) for uniform reporting by cohort analysis of treatment outcome in tuberculosis patients. Eur Respir J 1998, 12:505-510.
8. Silva D.R., Menegotto D.M., Schulz L.F., Gazzana M.B., Dalcin Pde T. Factors associated with mortality in hospitalized patients with newly diagnosed tuberculosis. Lung 2010, 188:33-41.
9. Getahun B., Ameni G., Biadgilign S., Medhin G. Mortality and associated risk factors in a cohort of tuberculosis patients treated under DOTs programme in Addis Ababa, Ethiopia. BMC Infect Dis 2011, 11:127. 10.1186/1471-2334-11-127.
10. Mugusi F.M., Mehta S., Villamor E., Urassa W., Saathoff E., Bosch R.J., et al. Factors associated with mortality in HIV-infected and uninfected patients with pulmonary tuberculosis. BMC Public Health 2009, 9:409. 10.1186/1471-2458-9-409.
11. Waitt CJ, Squire SB. A systematic review of risk factors for death in adults during and after tuberculosis treatment. Int J Tuberc Lung Dis. Forthcoming 2011.
12. Dodor E.A., Afenyadu G.Y. Factors associated with tuberculosis treatment default and completion at the Effia-Nkwanta Regional Hospital in Ghana. Trans R Soc Trop Med Hyg 2005, 99:827-832.
13. Obiri-Danso K AL, Edoh DA. Cure rate of tuberculosis patients using DOTS programme in Kumasi metropolis, Ghana. The Internet Journal of Pulmonary Medicine; 2009; 11.
14. Munoz-Sellart M., Cuevas L.E., Tumato M., Merid Y., Yassin M.A. Factors associated with poor tuberculosis treatment outcome in the Southern Region of Ethiopia. Int J Tuberc Lung Dis 2010, 14:973-979.
15. Adjei A.A., Adiku T.K., Ayeh-Kumi P.F., Hesse I.F. Prevalence of human immunodeficiency virus infection among tuberculosis suspect patients in Accra, Ghana. West Afr J Med 2006, 25:38-41.
16. Abdool Karim SS, Naidoo K, Grobler A, Padayatchi N, Baxter C, Gray A, et al. Timing of initiation of antiretroviral drugs during tuberculosis therapy. N Engl J Med. 362:697-706.
17. Manosuthi W., Chottanapand S., Thongyen S., Chaovavanich A., Sungkanuparph S. Survival rate and risk factors of mortality among HIV/tuberculosis-coinfected patients with and without antiretroviral therapy. J Acquir Immune Defic Syndr 2006, 43:42-46.
18. Velasco M., Castilla V., Sanz J., Gaspar G., Condes E., Barros C., et al. Effect of simultaneous use of highly active antiretroviral therapy on survival of HIV patients with tuberculosis. J Acquir Immune Defic Syndr 2009, 50:148-152.
19. Whalen C., Horsburgh C.R., Hom D., Lahart C., Simberkoff M., Ellner J. Accelerated course of human immunodeficiency virus infection after tuberculosis. Am J Respir Crit Care Med 1995, 151:129-135.
20. Gandhi N.R., Moll A.P., Lalloo U., Pawinski R., Zeller K., Moodley P., et al. Successful integration of tuberculosis and HIV treatment in rural South Africa: the Sizonq'oba study. J Acquir Immune Defic Syndr 2009, 50:37-43.
21. Howard A.A., El-Sadr W.M. Integration of tuberculosis and HIV services in sub-Saharan Africa: lessons learned. Clin Infect Dis 2010, 50(Suppl 3):S238-S244.
22. Maher D. Re-thinking global health sector efforts for HIV and tuberculosis epidemic control: promoting integration of programme activities within a strengthened health system. BMC Public Health 2010, 10:394. 10.1186/1471-2458-10-394.
23. Colebunders R., Bastian I. A review of the diagnosis and treatment of smear-negative pulmonary tuberculosis. Int J Tuberc Lung Dis 2000, 4:97-107.
24. Holtz TH, Kabera G, Mthiyane T, Zingoni T, Nadesan S, Ross D, et al. Use of a WHO-recommended algorithm to reduce mortality in seriously ill patients with HIV infection and smear-negative pulmonary tuberculosis in South Africa: an observational cohort study. Lancet Infect Dis. Forthcoming 2011.
25. Lawn S.D., Ayles H., Egwaga S., Williams B., Mukadi Y.D., Santos Filho E.D., et al. Potential utility of empirical tuberculosis treatment for HIV-infected patients with advanced immunodeficiency in high TB-HIV burden settings. Int J Tuberc Lung Dis 2011, 15:287-295.
26. Dimairo M., MacPherson P., Bandason T., Zezai A., Munyati S.S., Butterworth A.E., et al. The risk and timing of tuberculosis diagnosed in smear-negative TB suspects: a 12 month cohort study in Harare, Zimbabwe. PLoS One 2010, 5:e11849. 10.1371/journal.pone.0011849.
27. Dheda K., Davids V., Lenders L., Roberts T., Meldau R., Ling D., et al. Clinical utility of a commercial LAM-ELISA assay for TB diagnosis in HIV-infected patients using urine and sputum samples. PLoS One 2010, 5:e9848.
28. Lawn S.D., Edwards D.J., Kranzer K., Vogt M., Bekker L.G., Wood R. Urine lipoarabinomannan assay for tuberculosis screening before antiretroviral therapy diagnostic yield and association with immune reconstitution disease. AIDS 2009, 23:1875-1880.
29. Theron G, Peter J, van Zyl-Smit R, Mishra H, Streicher E, Murray S, et al. Evaluation of the Xpert(R) MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting. Am J Respir Crit Care Med. Forthcoming 2011.
30. Greenberg A.E., Lucas S., Tossou O., Coulibaly I.M., Coulibaly D., Kassim S., et al. Autopsy-proven causes of death in HIV-infected patients treated for tuberculosis in Abidjan, Cote d'Ivoire. AIDS 1995, 9:1251-1254.
31. Gutierrez E.B., Zanetta D.M., Saldiva P.H., Capelozzi V.L. Autopsy-proven determinants of death in HIV-infected patients treated for pulmonary tuberculosis in Sao Paulo, Brazil. Pathol Res Pract 2002, 198:339-346.
32. Newell J.N., Baral S.C., Pande S.B., Bam D.S., Malla P. Family-member DOTS and community DOTS for tuberculosis control in Nepal: cluster-randomised controlled trial. Lancet 2006, 367:903-909.
33. Thiam S., LeFevre A.M., Hane F., Ndiaye A., Ba F., Fielding K.L., et al. Effectiveness of a strategy to improve adherence to tuberculosis treatment in a resource-poor setting: a cluster randomized controlled trial. JAMA 2007, 297:380-386.
34. Wright J., Walley J., Philip A., Pushpananthan S., Dlamini E., Newell J., et al. Direct observation of treatment for tuberculosis: a randomized controlled trial of community health workers versus family members. Trop Med Int Health 2004, 9:559-565.
35. Bustamante-Montes L.P., Escobar-Mesa A., Borja-Aburto V.H., Gomez-Munoz A., Becerra-Posada F. Predictors of death from pulmonary tuberculosis: the case of Veracruz, Mexico. Int J Tuberc Lung Dis 2000, 4:208-215.
36. Gajalakshmi V., Peto R., Kanaka T.S., Jha P. Smoking and mortality from tuberculosis and other diseases in India: retrospective study of 43000 adult male deaths and 35000 controls. Lancet 2003, 362:507-515.
37. Oursler K.K., Moore R.D., Bishai W.R., Harrington S.M., Pope D.S., Chaisson R.E. Survival of patients with pulmonary tuberculosis: clinical and molecular epidemiologic factors. Clin Infect Dis 2002, 34:752-759.
38. Zachariah R., Spielmann M.P., Harries A.D., Salaniponi F.M. Moderate to severe malnutrition in patients with tuberculosis is a risk factor associated with early death. Trans R Soc Trop Med Hyg 2002, 96:291-294.